Edition:
India

Amedica Corp (AMDA.OQ)

AMDA.OQ on NASDAQ Stock Exchange Capital Market

3.74USD
17 Nov 2017
Change (% chg)

$0.28 (+8.09%)
Prev Close
$3.46
Open
$3.57
Day's High
$3.85
Day's Low
$3.46
Volume
11,677
Avg. Vol
10,722
52-wk High
$13.08
52-wk Low
$2.97

Chart for

About

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and... (more)

Overall

Beta: -2.13
Market Cap(Mil.): $10.59
Shares Outstanding(Mil.): 36.26
Dividend: --
Yield (%): --

Financials

BRIEF-Amedica announces reverse stock split

* Amedica Corp - ‍announced a 1-for-12 reverse stock split of its issued and outstanding common stock​ Source text for Eikon: Further company coverage:

10 Nov 2017

BRIEF-Amedica submits 510(k) application to FDA for Valeo C+CSC with Lumen

* Amedica submits 510(k) application to FDA for Valeo C+CSC with Lumen Source text for Eikon: Further company coverage:

06 Nov 2017

BRIEF-AMEDICA ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

* AMEDICA ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

03 Oct 2017

BRIEF-‍Amedica announces adjournment of special meeting of stockholders​

* ‍Amedica announces adjournment of special meeting of stockholders​

07 Sep 2017

BRIEF-Amedica receives NASDAQ listing determination, plans to request hearing

* Amedica receives NASDAQ listing determination; plans to request hearing Source text for Eikon: Further company coverage:

26 Aug 2017

BRIEF-‍Amedica files for non-timely 10-Q ​

* ‍Amedica Corp files for non-timely 10-q - sec filing ​ Source text - http://bit.ly/2i5VeDu Further company coverage:

16 Aug 2017

BRIEF-Amedica announces delayed filing of quarterly report on form 10-Q

* Amedica announces delayed filing of quarterly report on form 10-Q and receipt of nasdaq letter

26 May 2017

Competitors

Earnings vs. Estimates